As well, inactivation of TRPV1 accelerates the development of metabolic disorders such as hypertension, atherosclerosis, obesity, and fatty liver, whereas TRPV1 agonist activation protects against these metabolic diseases [25, 55, 57, 58]. The gene discussed is TRPV1; the disease is Obesity.